Showing results (1251-1260 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|March 30, 2017
The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy SubjectsKa Lai Yee, Sauzanne G Khalilieh, Rosa I Sanchez, et al.
Clinical Drug Investigation|December 22, 2021
The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]-BI 425809 in Healthy MalesUte Burkard, Michael Desch, Yury Shatillo, et al.
Clinical Drug Investigation|September 1, 2019
Tropicamide/Phenylephrine/Lidocaine Intracameral Injection: A Review in Cataract SurgeryEmma D Deeks
Clinical Drug Investigation|September 7, 2019
Mecapegfilgrastim in Chemotherapy-Induced Neutropenia: A Profile of Its Use in ChinaZaina T Al-Salama, Susan J Keam
Clinical Drug Investigation|August 23, 2019
Single-Dose Pharmacokinetics and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Subjects with Severe Renal Function ImpairmentPatricia N Sidharta, Ivan Ulč, Jasper Dingemanse
Clinical Drug Investigation|September 30, 2022
Effects of Cannabidiol on Appetite and Body Weight: A Systematic ReviewJoaquim S Pinto, Fátima Martel
Clinical Drug Investigation|October 8, 2022
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) TrialAmber van Broekhoven, Niekbachsh Mohammadnia, Max J M Silvis, et al.
Clinical Drug Investigation|March 12, 2021
Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-AnalysisHsin-Yu Chen, Shih-Hsiang Ou, Chien-Wei Huang, et al.
Clinical Drug Investigation|March 13, 2021
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug InteractionsMatthew P Rutman, John R Horn, Diane K Newman, et al.
Clinical Drug Investigation|October 5, 2019
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung CancerDaniel Gallacher, Peter Auguste, Pamela Royle, et al.
Pageof 234